losartan has been researched along with calcimycin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, RS; Chiu, AT; Leung, KH; Lotti, VJ; Roscoe, WA; Smith, RD; Timmermans, PB | 1 |
Freeman, BA; Griendling, KK; Harrison, DG; Kurz, S; Münzel, T; Rajagopalan, S; Tarpey, M | 1 |
Anversa, P; Cheng, W; Cigola, E; Kajstura, J; Li, P; Malhotra, A; Meggs, LG | 1 |
Breitbart, H; Gur, Y; Lax, Y; Rubinstein, S; Zamir, N | 1 |
Ayajiki, K; Kashiwagi, A; Nishio, Y; Okamura, T; Shinozaki, K; Sugaya, T | 1 |
Han, HJ; Heo, JS; Lee, YJ | 1 |
6 other study(ies) available for losartan and calcimycin
Article | Year |
---|---|
AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arachidonic Acids; Astrocytes; Biphenyl Compounds; Calcimycin; Cattle; Cells, Cultured; Dinoprost; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Glioma; Imidazoles; Iodine Radioisotopes; Losartan; Macrophages; Male; Muscle, Smooth, Vascular; Prostaglandins; Pyridines; Radioimmunoassay; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Swine; Tetrazoles; Thromboxanes; Tumor Cells, Cultured | 1992 |
Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.
Topics: Acetylcholine; Angiotensin II; Animals; Antihypertensive Agents; Aorta; Arginine; Biphenyl Compounds; Calcimycin; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Hypertension; Imidazoles; In Vitro Techniques; Losartan; Male; Muscle Relaxation; Muscle Tonus; Muscle, Smooth, Vascular; NADH, NADPH Oxidoreductases; Nitric Oxide Synthase; Nitroglycerin; Norepinephrine; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Superoxides; Tetrazoles | 1996 |
Angiotensin II induces apoptosis of adult ventricular myocytes in vitro.
Topics: Alkaloids; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Apoptosis; Benzophenanthridines; Biphenyl Compounds; Calcimycin; Calcium; Cells, Cultured; Chelating Agents; Cytosol; Egtazic Acid; Enzyme Inhibitors; Imidazoles; Ionophores; Isoenzymes; Losartan; Myocardium; Phenanthridines; Protein Kinase C; Protein Kinase C-delta; Protein Kinase C-epsilon; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 1997 |
Angiotensin II induces acrosomal exocytosis in bovine spermatozoa.
Topics: Acrosin; Acrosome; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Calcimycin; Cattle; Exocytosis; Female; Humans; Imidazoles; Losartan; Male; Pyridines; Receptors, Angiotensin; Sperm Capacitation; Sperm-Ovum Interactions | 1998 |
Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Calcimycin; Culture Techniques; Endothelium, Vascular; Insulin Resistance; Losartan; Male; NADPH Oxidases; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phenylephrine; Protein Subunits; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; RNA, Messenger; Superoxides; Vasoconstriction; Vasoconstrictor Agents | 2004 |
ANG II increases 2-deoxyglucose uptake in mouse embryonic stem cells.
Topics: Alkaline Phosphatase; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biological Transport; Calcimycin; Calcium; Cell Line; Cell Proliferation; Deoxyglucose; DNA-Binding Proteins; Dose-Response Relationship, Drug; Embryo, Mammalian; Estrenes; Gene Expression; Glucose Transporter Type 1; Imidazoles; Inositol Phosphates; Losartan; Membrane Transport Proteins; Mice; Monosaccharide Transport Proteins; Neomycin; Octamer Transcription Factor-3; Phosphodiesterase Inhibitors; Protein Kinase C; Pyridines; Pyrrolidinones; Stem Cells; Transcription Factors; Type C Phospholipases; Vasoconstrictor Agents | 2005 |